Rail Vision confirmed the completion of its previously announced transaction to acquire a 51% ownership interest in Quantum Transportation. The…
For years, one of the biggest frustrations in cancer care has been watching immunotherapy succeed spectacularly in some diseases while…
GridAI Technologies Corp., recently named Marshall Chapin as the CEO of the company’s wholly owned subsidiary, GridAI, Inc., which operates…
Quantum computing is already affecting the cryptocurrency industry in several notable ways, and Bitcoin is increasingly at the center of that shift as investors reassess long-term…
ParaZero recently advanced the deployment of its multi-layered Counter-UAS solutions for military and homeland security applications The company operates at…
LIXTE is developing a first-in-class therapy designed to enhance the effectiveness of existing cancer treatments Its lead compound, LB-100, targets…
Scientists have identified a compound produced by gut bacteria that sharply improves how tumors respond to immunotherapy, offering a potential breakthrough for patients…
Cornell researchers have developed particles that can supercharge immunotherapy, offering a breakthrough approach to treating resistant cancers. The nanoparticles work in…
Rail Vision operates in large and growing markets for railway safety, collision avoidance, and autonomous train technologies supported by favorable…
ParaZero has successfully demonstrated the company’s DefendAir platform for the first time on European soil, following a distribution agreement that…